Kyle Evans Email

Director, Operations & Administration . LANDOS BIOPHARMA

Current Roles

Employees:
38
Revenue:
$7.6M
About
Landos Biopharma is a clinical-stage biopharmaceutical company focused on the discovery and development of first-in-class oral therapeutics for patients with autoimmune disease. BT-11, Landos' lead asset, is completing a Phase 2 trial in mild to moderate ulcerative colitis (UC) in the U.S. Europe and Russia, with plans to initiate a Phase 2 trial of BT-11 in moderate to severe Crohn's disease (CD). BT-11 is a small molecule that targets a novel immunometabolic pathway within the gastrointestinal tract, potentially providing a more effective treatment and an improved patient tolerability profile.
LANDOS BIOPHARMA Address
1800 Kraft Drive
Blacksburg, VA
United States
LANDOS BIOPHARMA Email

#1 Startup Dataset

Growth rates, revenue data, direct competitors and contact details.